Deepak Bhatt, MD, MPH, MBA, reviews the efficacy and safety data of inclisiran, highlighting its long-term effects and noting that injection site reactions are among the most prominent adverse reactions associated with this medication.
Greater Salivary Rates Linked to Lower Levels of Psoriasis Disease Severity
Don't Miss a Beat: Semaglutide and the Future of Kidney Disease, with Brendon Neuen, MBBS, PhD
Patients with Crohn’s Disease Satisfied with Switch to Adalimumab Biosimilar SB5
Diabetes Dialogue: FLOW Trial and Semaglutide's Benefit in Chronic Kidney Disease
Oral PCSK9 inhibitor Significantly Reduces LDL-C in Hypercholesterolemia
Specific Inflammatory Markers Linked to Depression in Patients with Psoriasis